Model graphic

Model

Summary

The primary motivation for modeling the biological systems is to predict and optimize performance of components use in experiments. As our goal is to develop a hepatocellular carcinoma therapy we must do it in controllable way, and knowledge of components used for this process is crucial. An uncontrolled and rapid cell death can lead to a dangerous organism response. However if we do not understand how the system works inside the cell, we would not be able to achieve our goal as well. Therefore, we developed the models are designed to find the anwser to these questions. We used differential equations and experimental data combined to provide insight into the components we are using, and to optimize our way into HCC therapy.

Therapeutic delivery model

The first model focuses on the delivery of the therapeutic agent to the tumor. It uses a system of differential equations to model the perfusion of a contrast agent through the blood and into the cells, based on data from multiphase CT scans of HCC patients. This analysis is crucial for assessing the risks of non-specific therapy. The models highlight that the therapeutic agent will inevitably interact with healthy cells, and by describing the system mathematically, they can create risk models for these off-target effects. The model was fitted to data from 104 patients with HCC lesions and found a statistically significant increase in the permeability of tumor cells compared to healthy liver cells, by analyzing contrast agents radiodensity dynamics. The increased permeability of the tumor has important implications for therapy. It suggests that a higher concentration of the therapeutic agent will reach the tumor compared to healthy tissue. This is a crucial finding for determining the correct dosage in future experiments and for developing risk models for the effects on healthy cells. The model is relatively simple, and uses prexisting data often used in diagnostics, allowing additional information gain, without increasing the diagnostic workload.

Kinetics of toehold system

The second model tackles the expression of the toehold switch itself and with it, its reporter gene. This model is more complex as it involves the kinetics of transcription, translation, and the interaction of the toehold switch with its trigger sequence, but its robust structure allows for extensive insight. This model uses a system of differential equations to describe the concentration of the different components of the system over time. It considers the transcription of the toehold and trigger, the formation of the toehold-trigger complex, and the translation of the reporter protein. The model also includes a "leaky" expression term, which accounts for the production of the reporter protein even in the absence of the trigger. One of models findings is that the amount of reporter protein produced is not directly proportional to the amount of trigger sequence present. Instead, there is a complex relationship that depends on the rates of transcription, translation, and degradation of the different components. This is a critical insight for designing a system that is both sensitive and specific. The model also allows the researchers to estimate the real parameters of their system, such as the rates of transcription and translation, from experimental data. The model, while needs finding parameters of various steps of the process, amy be applied to single cell analysis using flow cytometry allowing for the extensive analysis of impact of therapeutic injection into the cell.

The general conclusion of the modeling work is that a quantitative, model-based approach is essential for the successful design and implementation of this cancer therapy. These models provide a framework for understanding the complex interplay between the delivery of the therapeutic agent and the kinetics of the toehold switch. They allow to move beyond a purely qualitative understanding of their system and to make quantitative predictions that can be tested experimentally. Ultimately and hopefully, this will lead to a more effective and safer therapy for HCC.

Modeling the toehold delivery

While the system designed to combat the cancer cells is crucial, the broader context has to be adressed, as the effectivness of the therapy is limited by its weakest link. Final result of treatment is supposed to be eradication of cancer cells and such an effect is not without its consequences. Excessive pyroptosis can trigger a dysregulated and overwhelming inflammatory response, resulting in systemic inflammation. As such it is paramount to predict correct tempo of death of cells as one too fast may be dangerous, and one too slow would be ineffective.

Changes in vascularization are hallmark features of hepatocellular carcinoma (HCC) development and progression. Angiogenesis is stimulated by the hypoxia occuring within enlarging tumors due to insufficient oxygen delivery which promotes new vessel creation as a compensatory mechanism. This vessel sprouting aims to improve nutrient and oxygen delivery but simultaneously generates aberrant vascular networks characterized by tortuosity, leakiness, and irregular flow dynamics. Such abnormal vessels lead to heterogeneous perfusion and altered delivery kinetics of substances, including therapeutic agents.
Given these vascular and permeability differences, we speculate that it is feasible to measure and compare the permeability characteristics of HCC lesions with normal liver tissue using contrast-enhanced imaging modalities such as multiphase CT. Quantitative imaging parameters reflecting tumor vessel permeability and perfusion can serve as non-invasive biomarkers to assess tumor angiogenesis, monitor disease progression, and potentially predict therapeutic delivery efficacy using a simple model, based on CT scans, often performed as diagnostic procedure.

Perfusion of cells

Computer tomography is a noninvasive medical imaging procedure that uses specialized X-ray equipment and computer processing to create detailed cross-sectional images, or "slices," of the body's internal structures. Measuring the attenuation of X-ray beam allow for imaging soft and dense tissues of the organisms in various shades of gray. As the data is gathered form multitude of angles, it is possible to reconstruct all the individual "snapshots" into two-dimensional cross-sectional images (slices) of the internal organs, bone, and blood vessels. These slices can also be digitally "stacked" to form three-dimensional (3D) images. Difference of contrast allows to recognise organs, and normal tissue, and in extension allows to diagnose disease, trauma, or abnormalities (like tumors, infections, or blood clots), and to plan or guide medical procedures (like surgery or radiation therapy). They provide much greater clarity and detail on soft tissues and internal organs than conventional X-rays, while being significantly less invasive compared to biopsy.

While CT scans can distinguish between tissues of different densities, many soft tissues and organs have very similar densities, making them hard to tell apart. To solve this, contrast agents (or contrast media) are used to temporarily enhance the visibility of specific areas. The most common contrast agents for CT are iodine-based. Iodine has a high atomic number, which makes it very effective at attenuating X-rays. When an iodine-based contrast agent is injected into the bloodstream, it travels throughout the body, accumulating in different tissues and organs. This causes the areas where it is present—such as blood vessels, tumors, or inflamed tissues—to appear much brighter on the CT scan, creating a sharp contrast against their surroundings.

To ensure the contrast agent reaches the target area quickly and at a high concentration, diffusing into tissues of interest, and not just contributing to the background noise due to diffusion, it is often administered as a bolus injection. This means a large volume of the contrast medium is injected rapidly into a vein, typically in the arm. The timing of the CT scan relative to the injection is critical. By carefully controlling this timing, radiologists can capture images during specific circulatory phases. For example:

  • Arterial Phase: Scanning shortly after injection highlights the arteries.
  • Venous Phase: Scanning slightly later shows the organs as they are perfused with contrast-rich venous blood.
  • Delayed Phase: Scanning several minutes later can reveal how organs like the kidneys and liver are processing and excreting the agent, which can be important for diagnosing certain conditions

The Hounsfield Unit (HU) is the standard quantitative scale used to describe radiodensity in computed tomography (CT) images. This scale precisely measures the degree to which different materials attenuate X-rays, translating these physical properties into the shades of gray you see on a scan. Pure water is the neutral baseline, defined as 0 HU, while air is defined as -1000 HU. Using this scale, doctors can identify different tissues. For instance, soft tissues like muscle and organs typically fall within a +40 to +80 HU range, while fat has a negative value of around -100. This precise numerical system allows for the clear differentiation of tissues, even those with very similar densities, and is fundamental to the diagnostic power of CT imaging. Contrast agent however increase radiodensity of body parts they reside in, allowing for analysis of changes of blood flow or permeability of cells or intracellular spaces.

Modeling the perfusion

The goal is to model how the organs and lesions of choice are reacting to changing concentration of contrast in local vicinity. Their perfusion would be then modeled using rates of diffusion of contrast into the area of interest, that is by measuring changes of HU in these areas.

The dye is injected into the vein, and contributes to attenuation of the Blood, that the CT scan is gathering during the arterial phase. While quick, the injection is not instantaneous and may range between injecting 3-5 ml/s of dye, with the total volume being variable as well, and dependent on the patient. The increasing contrast concentration in the vessels around the cells causes it to diffuse into the area of interest, as well as into the Cells themselves. As it is a diffusion reaction, the rate is dependent on the gradient between the two spaces, with a rate corresponding to permeability between the areas. Once the contrast stops being injected, the molecules of dyes are starting to disperse across all of the organism. The attenuation of the blood would slowly start to drop to reach the previous baseline levels, and the cells would then follow.

The equations to describe the system would be the ones bellow

$$ \frac{dB}{dt} = r_b(b+K -B) $$ $$ \frac{dC}{dt} = r_c(B-C) $$

The values of B and C are measured in HU. The attenuation of blood is dependent on the baseline level described by \(b\), rate of diffusion of contrast in blood, called \(r_b\), and then contrast injected in bolus symbolised in the equation as \( K \). As we control parameter of contrast injection in the blood, we may choose how long and how much do we apply the contrast, and without loss of generality, we assume that we start injecting at the time \(t=0\), and and at \(t=t_K\).

Variable \(C\), corresponding to the attenuation of cells inside of the area of interest, is described as the change of its own radiodensity with regard to the blood surrounding it. While the parameter of perfusion of cells \(r_c\) is unknown, it is the goal of the model to estimate this parameter.

Parameters and data fitting

To estimate the model we are using the Hepatocellular Carcinoma Multiphase CT Dataset published by Bartnik et al. [CYTOWANIE] This dataset contains the CT scans of 233 patients, with handcrafted masks for HCC lesions and organ masks, with 4 timepoints allowing for advanced analysis, and largescale analysis of HCC perfusion rate. Assumptions, however, for the procedure are in order, as the data is not available for every case. In figure 1 you can see the distribution of radiodensity of all of the observations with regard to the CT phases of acquisition which directly mean at what time since start of the injection were they performed. Usign Python libraries SimpleITK and pyradiomics we are able to use the masks provided by the radiologists to measure mean radiodensity of organs and lesions.

Figure 6
Figure 1. Ridge plot of mean radiodensity of organs and tumors.
Notice how histogram of tumors in phase 1 has moved to the left much faster than the standard liver cells.
Parameter Parameter value Source and explanation
b baseline Mean of radiodesity for the area at native phase
K 300 Target attenuation value in the blood [CYTOWANIE]
\(t_K\) 30 Estimation of time length of bolus
\(B(0)\) K+b Contrast injected at start of time
\(C(0)\) baseline Native conditions

Based on the avarage age and sex, we may conclude that avarage weight is around 80 kg, which would correspond to 120 of cc of contrast injected at 4 ml/s granting 30 seconds of injection. Initial timepoints of the equation were chosen by the author's notes, however, due to loss metric, the changes of possible acquisition time are included.

Solving of the above equations was performed with help of SciPy Python library. Estimation of the fitting was performed by solving the differential equation numerically with usage of SciPy library. The solved function was compared with observation via Root Mean Square Distance of observation to the function. The loss function had twice the sensitivity to the fitting than to time placement, helping with fitting more accurately. For area of interest's observations \(O(t,y)\) and \(r_b\), \(r_c\) the loss is defined by

$$ L(r_b, r_c, O) =min(\forall_{t\in[0,270]} (C_{r_b r_c}(t)-O_y)^2 + (t-O_t)^2) $$

and for entire set of observation the loss is defined by

$$ RMSD(r_b, r_c, \mathbb{O}) = \sqrt{\frac{\sum_{\forall O \in \mathbb{O}} L(r_b, r_c, O)}{|\mathbb{O}|} } $$

where \(\mathbb{O}\) is the set of observation for which we fit the model.

To correctly asses the baseline of \(r_b\), the model was fitted to the observations attributed to whole liver. Then with model fitted for healthy organ, the same \(r_b\) was used for fitting the model on the tumors for the same patient. This ensures comparable results regarding comparison of perfusion parameter, as well as is a step preventing overfitting the model, considering we have relatively small amount of observation per area of interest.

Shift of permability

Out of the 223 patients in dataset, only 138 had the recquired data for analysis. The patients that had no tumors masked, lacked baseline CT scan, dissallowing for calibration, were rejected. The ones that had been fitted, were filtered, removing wrongly fitted and entries with too big of an error (RMSD>200). If after this filtration patient did not have any tumors, he was deleted from dataset. Overall there was 104 patients to which model has fitted the parameters sufficiently well and the example results can be seen in the graphs below.

Figure 2
Figure 2. Line plot of predicted changes of attenuation of tumors over time. The model works even while the tumors are numerous
Figure 3
Figure 3. Line plot of predicted changes of attenuation of tumors over time. Example of tumor changing radiodensity quicker than healthy tissue

The model has been able to fit the parameters for around 75% of the tumors and patients in the dataset with sufficient data. Considering that fitting was performed only for one parameter for the tumors it may be considered success considering how complex of a system is the cancer environment. The error rate exhibits a hiperbolic distribution, with error rate quickly diminishing. However, it is unsuprising that error for healthy tissue is less than for tumors, considering the latter could have only optimized one parameter.

Figure 3
Figure 4. Histograms of distribution of \(r_b\) value and of error values.

Gathered parameters for permability of the tissues are shown on a figure 5. Comparing the observations of two populations result in confirmation of statistical significance of shift of distribution of \(r_c\) parameters between liver cells and tumor cells. The mean permability of tumor increases, which may correspond to increased angiogenesis of the lesion. The difference of the hiperatteuation of the lesions may correspond to the vascular changes dependent on HCC stage [1]. For this reason, the difference of \(r_c\) between the liver tissue and lesion tissue is calculated and shown in the figure 6.

Figure 3
Figure 5. Histograms of permability parameters for diffrent types of tissues.

Shift of permability is seen in the graph below, which is crucial information from perspective of delivery of substances to the lesions. There can be seen a wide range of values differentiating the individual tumors, and may be correlated to their stage and vascularity. HCC caused angiogenesis may result in new vessels, [2] but abnormalities resulting from it may lead to heterogeneous perfusion and altered delivery kinetics of substances. These changes of permability is measured by our model below, quantifying the vascular changes inside of the lesion.

Figure 3
Figure 6. Difference of lesions \(r_c\) to the liver's.
Delivery kinetics

Our model was developed to measure changes of permability of lesions, which it managed for 75% of patients with complete data. While the cancer changes are complex are for moddeling, as malignant cell changes are often not following standard models, we have shown that our models can show a statistical difference between populations of healthy, and unhealhty tissue. The parameter \(r_c\) interpreted by model as permability of the cells of interest is larger in tumor cells by \(0.0006\). This change may represent one of many changes of tumor environment, angiogenesis and growth of arterial branches, capilarisation of tumor, increased permability due to less rigorous control of vasculature expansion [1] or potentially other factors. The measured difference may be used to estimate the stage of the tumor, and could be applied to know how much therapeutic will be delivered to the cells, considering the permability will not change depending on the substance. The propotion of speed of therapeutic absorbion, assuming uniform distribution of it across the organ, for tumor \(C_t\) and healthy liver cells \(C_l\) and their corresponding \(r_c\) parameters \(r^{C_t}_c\) and \(r^{C_l}_c\) respectively, would be than $$ \frac{\frac{dC_t}{dt}}{\frac{dC_l}{dt}}= \frac{r^{C_t}_c}{r^{C_l}_c} $$ which after substituting the parameters for respective means of their own: $$ \frac{dC_t}{dC_l} = \frac{0.0024+0.0006}{0.0024}= 1.25 $$ Knowing the difference of intake of therapeutic is an important step in understanding the correct dosage for future experiments. This model is an important step for our team in modeling the intuition of lesions kinetic behavior of molecules uptake, which will serve as an important entry point should the project advance to the next stages. Furthermore, the results highlights the risks of the non-specific therapy, as the therapeutic will be interacting with healthy cells, but our attempt to describe the system will help with creation of risk models for effects on healthy cells.

The toehold expression system

The toehold switch is an elegant yet complex regulatory mechanism. By using Ordinary Differential Equations (ODEs) to model its kinetics and resulting expression, we are moving the project from a purely biological experiment into rigorous synthetic engineering. This modeling step is critical for three main reasons: prediction and optimization, parameter identification, and system design iteration.

The model

Our model attempts to understand the toehold expression system and derivate the parameters for toeholds, given the experimental results. We achive this by creating a complex and robust model which as the end result predicts how much GFP the construct is able to express. By solving the equations for parameters, we may derive the real parameters for effectivnes of our ryboswitches, their specifity and sensitivity.
Our system starts with the transfection of the cells with our plasmids containing sequence, allowing expression of toeholds inside the cell. These plasmids are translated, yielding the free toeholds in process. We take into our considaration degradation of both the plasmids and the toeholds, as well as their respective generation. These plasmids are expressing the toehold sequences, which are folding into their inactive form with hairpin established. Free toeholds have a affinity to a target seqence found in the alfafetoprotin mRNA. Once the toehold recognizes the particular sequence in the mRNA, the complex toehold-mRNA establishes and the toehold unravels into it's active form, designed to be able to express its reporter gene, in this case, GFP. In its active form, it is assumed that the rybosomes may attach to the unfolded toehold, and start translating the sequence that is protected by toeholds hairpin. However, we are predicting that the leackage of expression may occur, and result in translation even without the activated toehold. The inactive toeholds with translation ongoing may by created from hairpin not being of enough obstruction of the ribosome, or by the detachment of toehold from AFP mRNA. The whole system may be described with the following equations:

$$ \frac{dP}{dt}= -\gamma_p $$ $$ \frac{dA}{dt}=-k_a A *T +k_dAT $$ $$ \frac{dT}{dt} = k_p P - \gamma_t T -k_a A * T + k_dAT - k_{off} T + k_tTR $$ $$ \frac{dAT}{dt}= k_a A * T - k_dAT - k_{on} AT + k_t ATR $$ $$ \frac{dATR}{dt}= k_{on} AT - k_t ATR - k_d ATR + k_a TR*A$$ $$ \frac{dTR}{dt}= k_{off} T - k_t TR + k_d ATR - k_a TR*A$$ $$ \frac{dR}{dt}= -k_{on} AT + k_t ATR -k_{off} T + k_t TR $$ $$ \frac{dG}{dt}= k_t ATR + k_t TR - \gamma_G G $$

Let's introduce a notation to track the concentration of all units of molecule, by using "blackboard board" letters, meaning that it tracking the concentration of all the toeholds, regardless of their association. For example $$ \mathbb{T}= T+ AT + ATR+ TR$$ as each unit of this complexes contains one toehold. As the model is quite complex, we may find a ways to reduce it or to find cases where it simplifies.. However before we start with biological explanations of phenomens, we may conduct the properties of the system from the equations themselves.

Toehold concentration stabilization

As the toeholds are directly transcribed from the plasmids transfected into the cells, we may ensure try to predict how much of toeholds will be in the cell itself. Although the ammount, and thus the concentration in the volume of cell is unknown for us, as it is heavily reliant on cell type, transfection success and probabilistic distibution of the plasmids inside of the carrier, we may not assume the exact starting point. However we may know that \( P(0)= P_0 \geq 0\) . Knowing that plasmid DNA lasts and remains expressed after transfection for a significant ammount of time, and its removal is mostly due to dilution when cells divide and plasmid degrades over time, as it is not mantained by cell genome machinery. However in terms of immidiate expression it means that the rate of the dimminishing of plasmid concentration \(\gamma_p\) is small, and may be assumed that it is negligible in terms of immidiate expression, meaning $$ \frac{dP}{dt} \approx 0 $$ This serves another purpouse as well, while trying to find a stationary state, without this assumption, the only stationary state for \(P\) is for the variable to be equal to zero. As the \(k_p P\) is the only factor in differential equation for \(T\), which is not dependent on T it follows that the toehold also has it's stationary state at \(T=0\). Thus to meaningluffy analyse the modelwe must assume at least local stability for \(P\). Once we do the change of toehold concentration and every single of its complexes is then $$ \frac{d\mathbb{T}}{dt} = \frac{dT}{dt} + \frac{dAT}{dt} + \frac{dATR}{dt} + \frac{dTR}{dt} = k_p P_0 - \gamma_t T$$ meaning that the total toehold units, no matter the interactions, and assuming \(\mathbb{T}(0) = 0\), this equal to: $$ \forall_{t>t_{stable}} \mathbb{T}(t) \approx \frac{k_p P_0}{\gamma_t} $$ However, caution has to be taken regarding the time, it would take to achieve such a state. One may ask when such a state would be achieved, and if it is fast enough to not have a significant effect on other parts of equation. As we can see that the rate of approaching the stable toehold concentration is rate of toehold degradation $'\gamma_t'$, and to estimate whether toeholds are transcribed fast enough is to estimate said parameter.

Rybozomes as non-limiting factor

Rybosomes are inherent part of our equation, as they are necessary to express our protein of choice. However, abundance of ribosomal units in cell does, which are present at ~10^7 per cell, suggest that their presence is not a limiting factor in the equation. As the equation involving ribosomes are conserving them, this means that $$ \frac{d\mathbb{R}}{dt} = \frac{dR}{dt} + \frac{dTR}{dt} + \frac{dATR}{dt} = 0$$ This property, alongside with knowledge of overwhelming ribosomal presence in the cell, leads us to assume that the state change to binding rybosomes is dependent on the affinity of binding of rybosomes to the mRNA and not the concentration of rybosomes themselves, as these may not be the limiting factor, which is represented in the equations.

Absence of trigger sequence

AFP is a nucleotide polymer which contains trigger sequence for all of our toeholds. However, it follows that in cells with no target mRNA we would expect no expression, provided the toeholds had perfect specifity. We would like to represent this in our model, as in our experiment we transfected the HEK293T cell line as the negative control. Considering that the AFP content is zero, the model simplifies to the following set of equations. $$ \frac{dP}{dt} = -\gamma_p $$ $$ \frac{dT}{dt} = k_p P - (\gamma_t + k_{off}) T + k_t TR $$ $$ \frac{dTR}{dt} = k_{off} T - k_t TR $$ $$ \frac{dR}{dt} = -k_{off} T + k_t TR $$ $$ \frac{dG}{dt} = k_t TR - \gamma_G G $$ Once again assuming the \(\gamma_p\) is sufficiently small we may calculate the stability of the system. $$ \frac{dT}{dt}=0 \leftrightarrow \frac{k_p P}{\gamma_t} $$ $$ \frac{dTR}{dt}=0 \leftrightarrow \frac{k_{off} T}{k_t} $$ $$ \frac{dG}{dt}=0 \leftrightarrow \frac{k_{t}}{\gamma_G}TR $$

Apllication to experimental results

To recap the experiment, two cell lines HepG2 and HEK293T are transfected with toeholds of our choice. After incubation for two days, the cells are then measured on flow cytometry experiment to gather data on their fluorescence parameters. The results are then normalised, allowing us to compare the ON/OFF ratio. The positive and negative controls allow us te see the maximum possible fluorescence, assuming the toeholds do not obstruct the translation of reporter gene. Normalising it to GFP fluorescence of positive control, allows to simplify the model without the loss of generality. In the table 2 we are presenting the results of the experiments:

Expreimental result Model meaning Toehold 21
ON/OFF ratio \({k_{on}}/{k_{off}}\) 30,7
GFP in HepG2 \(G^* \) 0.4
GFP in HEK293T \( G^* \) when \(A = 0\)
0.013
Table 2. Experimental results of flow cyotmetry, and their interpretation in the model.

From this we may calculate the parameters for the negative control. Assuming \(A = 0\) $$ G^* = \frac{k_{t}}{\gamma_G}TR = \frac{k_{t}}{\gamma_G} \frac{k_{off} }{k_t}T= \frac{k_{t}}{\gamma_G} \frac{k_{off} }{k_t} \frac{k_p }{\gamma_t} P =\frac{k_{off} k_p}{\gamma_G \gamma_t} P $$

General solution

Finally, we would try to solve for the stable state for our experiment with alfafetoprotin. While the calculations are quite long, as the system is not simplified with AFP it is possible to solve for steady state of GFP. $$ G^* = \frac{k_t}{\gamma_G} (ATR^* + TR^*) $$ With the steady states of \(ATR\) and \(TR\) are respectively: $$ATR^*= \frac{k_{on}k_a k_p }{k_t k_d \gamma_t} P A^*$$ $$ TR^*=\frac{k_{off} k_p }{k_t \gamma_t } P $$ Resulting in: $$ G^* = \frac{k_{p} }{\gamma_G \gamma_t }P (\frac{k_{on} k_a}{k_d}A + k_{off} )$$ As the solution of steady stated of \(A\) and \(R\) is arbitrary, the choice of the value of them may depend on the results experiment, yet it is shown in the solutions that concentration of the ribosomes does not matter under previous assumptions. Solving of above equations will yield important knowledge about the nature and effectiveness of the toeholds, with informations regarding their binding efficacy to target sequence, and leakage expression.

While sufficient data was not gathered in time regarding the individual parameters, like GFP half-time or plasmids expression rate, to supply the model estimations may be made from the literature. Limitations of the model may arise in experimental cases, particulary in cells with present AFP, although not abundant. Yet analysis of the model provides important insights into the processes occuring in the cell after transfection with plasmids. The model allows us to grasp which steps of the process are crucial for effective protein expression, highlighting less intuitive parameters such as the plasmid expression rate or the reporter gene degradation. Estimation of these parameters is crucial for future analysis, as computer simulations do not accurately represent the pleathora of interactions happening inside of the cell. Morover the model has a potenitial for as single cell analysis usage, by modeling parameters based on individual cell's fluorescence gathered during cytometry.

Nonetheless, the current analysis and model framework offer immediate, powerful predictive capabilities for understanding the kinetic bottlenecks and determining the optimal expression strategy following transfection. The model's versatility, particularly its capacity for single-cell parameterization using flow cytometry data, suggests a great potential to move beyond population averages and create a truly personalized, quantitative picture of gene expression dynamics, paving the way for significantly optimized and targeted synthetic biology applications in the future.

Citations

  1. Rhee, H., Park, Y. N., & Choi, J.-Y. (2024). Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment. Korean Journal of Radiology, 25(10), 887. https://doi.org/10.3348/kjr.2024.0307
  2. Yao, C., Wu, S., Kong, J., Sun, Y., Bai, Y., Zhu, R., Li, Z., Sun, W., & Zheng, L. (2023). Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biology & Medicine, 20(1), 25–43. https://doi.org/10.20892/j.issn.2095-3941.2022.0449
  3. Oda, S., Utsunomiya, D., Nakaura, T., Kidoh, M., Funama, Y., Tsujita, K., & Yamashita, Y. (2018). Basic Concepts of Contrast Injection Protocols for Coronary Computed Tomography Angiography. Current Cardiology Reviews, 15(1), 24–29. https://doi.org/10.2174/1573403x14666180918102031
  4. Statistics Poland - Goverment organization - https://stat.gov.pl/obszary-tematyczne/zdrowie/zdrowie/odsetek-osob-w-wieku-powyzej-15-lat-wedlug-indeksu-masy-ciala-bmi,23,1.html